MiNK Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$22,457,859 over the previous period. Total operating expenses were $22,921,105.
Profit Margin
| 2019 | 689.62K | -25.91M | -3757.73% |
|---|---|---|---|
| 2020 | 0 | -15.67M | |
| 2021 | 0 | -23.11M | |
| 2022 | 2.70B | -24.77M | -0.92% |
| 2023 | 0 | -22.45M |
INKT Income Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Revenue | |||||
Revenue | 0 | 2.70B | 0 | 0 | 689.62K |
Cost of revenue | 204.61K | 30.94B | 28.35B | 55.06K | 0 |
Gross profit | -204.61K | -28.24B | -28.35B | -55.06K | 689.62K |
Operating exp. | |||||
Research and development | 15.48M | 23.11M | 13.96M | 9.50M | 19.65M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 22.92M | 30.94M | 18.60M | 10.79M | 23.48M |
Operating income | -22.92M | -30.94M | -28.35M | -14.63M | -22.28M |
Other income (expenses), net | 463.24K | 2.95M | -1.85M | -1.60M | -1.51M |
Income before tax | -22.45M | -27.99M | -30.21M | -16.23M | -23.80M |
Income tax expense | 0 | -3.21M | -7.09M | -560.38K | 2.11M |
Net income | -22.45M | -24.77M | -23.11M | -15.67M | -25.91M |
Earnings per share | |||||
Basic EPS | -0.65 | -0.74 | -0.69 | -0.47 | -0.78 |
Diluted EPS | -0.65 | -0.74 | -0.69 | -0.47 | -0.78 |
| Data source | Data source | Data source |